WebTAMPA, Fla., July 29, 2024 (GLOBE NEWSWIRE) -- Inc. (OTCQB: HCYT) (“H-CYTE” or the “Company”), the owner and operator of innovative medical technology products and service WebH-Cyte is a Trademark by Medovex Corp., the address on file for this trademark is 1950 Airport Road Suite A, Atlanta, GA 30341 Trademark Introduction H-CYTE TRADEMARK …

www.sec.gov

WebApr 8, 2024 · ALPHARETTA, Ga., April 08, 2024 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on April 1, 2024, the Company entered into a securities purchase agreement with five purchasers pursuant to which the five purchasers invested in the Company an aggregate amount of … WebSep 8, 2024 · Overview H-CYTE, Inc is a hybrid-biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. During the last two... April 13, 2024 jean 19 1 42

GEORGIA

Web--H-CYTE Inc. the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute, announces it has raised $6 million in new funding. Lung ... WebNov 18, 2024 · About H-CYTE Corporation H-CYTE was formed to build and develop a diversified portfolio of innovative medical technology products and services to improve quality of life for patients. The DenerveX ® System is H-CYTE’s first product and is intended to provide long-lasting relief from pain associated with facet joint syndrome. For … WebAbout H-CYTE Corporation . H-CYTE was formed to build and develop a diversified portfolio of innovative medical technology products and services to improve quality of life for patients. The DenerveX ® System is H-CYTE’s first product and is intended to provide long-lasting relief from pain associated with facet joint syndrome. For biomedical ... la bandera de la wiphala